Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Cristina Guarducci, Ph.D.

Concepts (71)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Receptors, Estrogen11202522411.020 Why?
Cyclin-Dependent Kinases120246600.700 Why?
Cyclin-Dependent Kinase 4520255610.650 Why?
Proto-Oncogene Proteins c-myc120249970.610 Why?
Cell Cycle1202429180.510 Why?
Cyclin-Dependent Kinase 6420253520.510 Why?
Protein Kinase Inhibitors4202556930.480 Why?
Drug Resistance, Neoplasm5202553360.480 Why?
Breast Neoplasms142025210620.470 Why?
Receptor, erbB-27202425920.370 Why?
Piperazines4202425460.340 Why?
Apoptosis2202495110.310 Why?
Pyridines4202428890.310 Why?
Antineoplastic Agents, Hormonal3201615340.210 Why?
Signal Transduction42025235900.210 Why?
Carcinoma, Lobular120224700.150 Why?
Genes, Retinoblastoma120181250.150 Why?
Xenograft Model Antitumor Assays1202436060.130 Why?
Carcinoma, Ductal, Breast1202210840.120 Why?
NF-kappa B1202324870.120 Why?
Neoplastic Cells, Circulating120219490.110 Why?
Retinoblastoma Protein120166660.100 Why?
Cell Line, Tumor32024170600.100 Why?
Estradiol2201619470.100 Why?
Antineoplastic Agents32025136390.080 Why?
Cell Proliferation12024104290.080 Why?
Gene Expression Regulation, Neoplastic1202486020.070 Why?
Tamoxifen220229640.060 Why?
Female1420253961590.050 Why?
Antineoplastic Combined Chemotherapy Protocols22020118620.050 Why?
Retinoblastoma Binding Proteins120211010.040 Why?
Apoptosis Regulatory Proteins1202311500.040 Why?
Antigen Presentation1202312500.040 Why?
Humans1420257660110.040 Why?
Mitochondrial Proteins120239750.040 Why?
Mice12024817860.030 Why?
Cell Count1202118230.030 Why?
E2F2 Transcription Factor12016350.030 Why?
Postmenopause2201625160.030 Why?
E2F1 Transcription Factor120161830.030 Why?
Receptors, Progesterone1202111520.030 Why?
Transcription Factor AP-212016780.030 Why?
Hepatocyte Nuclear Factor 3-alpha120161660.030 Why?
Biomarkers, Pharmacological120161620.030 Why?
Bayes Theorem1202323540.030 Why?
Animals220241687210.030 Why?
Phosphatidylinositol 3-Kinases1202428770.030 Why?
Intracellular Signaling Peptides and Proteins1202328800.030 Why?
Epidermal Growth Factor120166980.030 Why?
Tumor Cells, Cultured1202161110.030 Why?
Ubiquitin-Protein Ligases1202118940.020 Why?
Gene Expression Profiling2201895210.020 Why?
Aromatase Inhibitors120155180.020 Why?
Chromatin1202229790.020 Why?
Tumor Microenvironment1202339470.020 Why?
ROC Curve1201836180.020 Why?
Prognosis22022299150.020 Why?
Neoadjuvant Therapy1201828940.020 Why?
Disease-Free Survival1201668380.020 Why?
Neoplasm Metastasis1201548840.010 Why?
Disease Progression12021136150.010 Why?
Survival Analysis12016100860.010 Why?
Neoplasm Staging12018112080.010 Why?
Treatment Outcome22021652360.010 Why?
Double-Blind Method12016124330.010 Why?
Aged, 80 and over12018595260.010 Why?
Middle Aged220182230580.010 Why?
Mutation12016301870.010 Why?
Young Adult12018598700.010 Why?
Aged120181712330.000 Why?
Adult120182231090.000 Why?
Guarducci's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (71)
Explore
_
Co-Authors (23)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.